"These results must be framed within the broader context of a changing landscape of follow-on biologics." "The biologics landscape is evolving, driven by the growth of biosimilars, the ...

Biocon attributed last year’s higher profitability to a one-time gain from Bicara and proceeds from Biocon Biologics' partial divestment of the BFI business. Meanwhile, consolidated revenue rose 7% on ...

The eligible products have been split into three categories. Category 1: Biopharmaceuticals (includes biologics, biosimilars and vaccines); complex generic drugs; patented drugs or drugs whose ...

LONDON--(BUSINESS WIRE)--Accenture (NYSE: ACN) has acquired Altus Consulting, a leader in consulting and digital transformation, to further strengthen its strategic advisory and delivery services ...

Newer medications, such as biologics, are improving the odds. There are a number of medications and lifestyle changes that can help with symptoms of Crohn’s disease. For many, these treatments ...

Pli­ant Ther­a­peu­tics has of­fi­cial­ly dis­con­tin­ued a mid-stage study of its chron­ic lung dis­ease treat­ment, less than a month af­ter the tri­al’s safe­ty board rec­om ...

RAMSEY, N.J. (AP) — RAMSEY, N.J. (AP) — Adma Biologics Inc. (ADMA) on Monday reported fourth-quarter net income of $111.9 million, after reporting a loss in the same period a year earlier.

Four years after Sanofi shelled out $125 million for global rights to Biond Biologics’ novel immune checkpoint inhibitor, the French pharma is handing the prospect back to Biond. The move is due ...

While second-generation antihistamines serve as the primary treatment, many patients require additional therapies, such as biologics, when symptoms remain uncontrolled. 1,2 Despite advances in ...

But it’s interesting. This the first time in my life I’m a consumer of a– we have consumer electronics. Now we have consumer biologics. And so that was shocking in a good way to me last year. I got a ...

All patients had an inadequate response or intolerance to conventional therapy. Around 60% were naive to biologics, Janus kinase (JAK) inhibitors, or sphingosine-1-phosphate receptor modulators ...

“[T]hat’s one of the reasons why we had been focused on Delaware and the growing biologics talent pool,” Keppel said Monday, according to local news service Town Square Delaware. This isn ...